More Upside Coming for a Popular Biotech ETF

Biotechnology stocks and exchange traded funds have plenty of detractors that, primarily citing lofty valuations for an industry that is almost always richly valued relative to the broader market, think declines are on the way. Biotech ETFs also have plenty of supporters. That much is highlighted...